INOTEK PHARMACEUTICALS CORP - COM (ITEK)

CUSIP: 45780V102

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
18,620,602
Share change
+8,203,420
Total reported value
$175,057,000
Price per share
$9.40
Number of holders
53
Value change
+$83,705,455
Number of buys
48
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 45780V102?
CUSIP 45780V102 identifies ITEK - INOTEK PHARMACEUTICALS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INOTEK PHARMACEUTICALS CORP - COM (ITEK) as of Q3 2015

As of 30 Sep 2015, INOTEK PHARMACEUTICALS CORP - COM (ITEK) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,620,602 shares. The largest 10 holders included Devon Park Associates, LLC, RHO CAPITAL PARTNERS INC, JENNISON ASSOCIATES LLC, FRANKLIN RESOURCES INC, RS INVESTMENT MANAGEMENT CO LLC, Point72 Asset Management, L.P., EverPoint Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Advisors LLC, and ORBIMED ADVISORS LLC. This page lists 53 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.